TriState Capital Bank

TriState Capital Bank is a specialized financial institution that provides commercial banking, liquidity management, and capital markets services to middle-market companies, with a significant vertical dedicated to the healthcare and life sciences sectors. Through its Healthcare Banking group, the company offers tailored financing solutions, including senior debt and revolving credit facilities, to clinical research organizations (CROs), medical device manufacturers, and pharmaceutical service providers. While not a drug developer itself, TriState Capital is a key financial partner for private equity-backed healthcare firms seeking growth capital or specialized lending products such as marketable securities-backed loans. In 2022, the bank was acquired by Raymond James Financial, though it continues to operate as an independent brand serving specialized niche markets. For a biotech analyst, TriState Capital represents a prominent source of non-dilutive financing within the middle-market healthcare ecosystem.